Leflunomide as a potential second-line drug in the treatment of sarcoidosis
Sarcoidosis is systemic granulomatosis of an unknown nature, the course of which varies from spontaneous remission to progression resulting in failure of organs and systems. The article presents a review of current approaches to treatment of sarcoidosis putting special emphasis on the use of the ant...
Main Authors: | A. A. Vizel, I. Yu. Vizel |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2019-09-01
|
Series: | Туберкулез и болезни лёгких |
Subjects: | |
Online Access: | https://www.tibl-journal.com/jour/article/view/1326 |
Similar Items
-
Assessment of the effect of alpha-tocopherol on the course of newly diagnosed pulmonary sarcoidosis: a comparative study
by: A. A. Vizel, et al.
Published: (2020-11-01) -
Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01) -
LEFLUNOMIDE IN RHEUMATOID ARTHRITIS: URGENT MATTERS OF PRACTICAL USE
by: Yuri Aleksandrovich Olyunin
Published: (2009-09-01) -
Reproductive function in women with sarcoidisis
by: I A Milova, et al.
Published: (2012-12-01) -
Leflunomide in clinical practice
by: Yuriy Aleksandrovich Olyunin
Published: (2014-03-01)